Bumble Inc. (NASDAQ: BMBL): HSBC Securities initiated coverage with a Buy rating and a $20.30 target price. The consensus target is $23.57, and shares closed on Tuesday at $14.79.
Carlisle Companies Inc. (NYSE: CSL): As Jefferies downgraded the stock to Hold from Buy, its $325 price target shrank to $290. The consensus target is $320, and shares closed on Tuesday at $253.45.
Comerica Inc. (NYSE: CMA): Odeon’s downgrade was from Buy to Hold with a $46 target price. The consensus target is $57.48. The stock closed on Tuesday at $39.99.
Dell Technologies Inc. (NYSE: DELL): Citing an AI-driven rebound in PC sales and growth in server sales, Zacks selected this as its Bull of the Day stock. Shares last closed at $68.93, which is up more than 34% in the past 90 days.
Domino’s Pizza Inc. (NYSE: DPZ): Oppenheimer reiterated an Outperform rating with a $450 target price. That compares with the $417.85 consensus target and Tuesday’s closing print of $379.22.
Edwards Lifesciences Corp. (NYSE: EW): Oppenheimer upgraded the stock to Outperform from Perform, but its $90 price target is less than the consensus target of $97.05. The shares closed at $70.37 on Tuesday.
Etsy Inc. (NASDAQ: ETSY): Evercore ISI reiterated an Outperform rating but reduced its target price to $85 from $105. The consensus target is $106.33. Tuesday’s close at $61.87 was down over 4% on the day.
Fisker Inc. (NYSE: FSR): BofA Securities resumed coverage with a Buy rating and has an $8 price target. The consensus target is $8.95. The stock closed almost 10% higher on Tuesday at $5.82 after the upgrade.
Flowserve Corp. (NYSE: FLS): Jefferies upgraded the stock to Buy from Hold and lifted its price target to $50 from $40. The consensus target is $43,60. The shares closed Tuesday’s session at $38.90.
Immunovant Inc. (NASDAQ: IMVT): Raymond James upgraded the shares to Outperform from Market Perform. Its $40 target price is well above the consensus target of $29.92. The stock closed Tuesday at $39.96, which was up 97% for the day after the company announced its experimental drug lowered an antibody tied to autoimmune diseases.
Luminar Technologies Inc. (NASDAQ: LAZR): BofA Securities resumed coverage with a Neutral rating and a $5 price target. The consensus target is $11.14. The stock closed over 6% lower on Tuesday at $4.01.
Sponsored: Tips for Investing
A financial advisor can help you understand the advantages and disadvantages of investment properties. Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to three financial advisors who serve your area, and you can interview your advisor matches at no cost to decide which one is right for you. If you’re ready to find an advisor who can help you achieve your financial goals, get started now.
Investing in real estate can diversify your portfolio. But expanding your horizons may add additional costs. If you’re an investor looking to minimize expenses, consider checking out online brokerages. They often offer low investment fees, helping you maximize your profit.
